In European market Poly Medicure wins patent battle against Braun Melsungen
The patent dispute between the two companies began at the Medica 2009 trade fair
B Braun melsungen (German pharmaceutical) entity is a well known brand in medical technology domain in Europe. However, recently B Braun melsungen has lost a patent dispute with the Indian competitor Polymedicure.
The research and development vertical of Polymedicure is approved by Ministry of Science & Technology Government of India to design & develop new and innovative products from Design to production in a short span of time using rapid prototyping 3 D printer CAD/CAM technology etc. The Indian entity possess ultra modern tool room with sophisticated machines like CNC wire cut, EDM and Vertical Machining Center.
B. Braun is pioneer in research and development of intravenous safety catheters with protection in numerous European countries.
When a physician applies such a catheter to a patient, a needle guard automatically protrudes over the tip when the needle is withdrawn from the arm. This protects the doctor and nursing staff.
It is a known fact that conventional catheters lack such a needle guard. Nurses and other healthcare personnel are routinely injured by the exposed, sharp lancet of the needle after use on a patient. The critical time where a percutaneous injury can occur is from the moment the needle is withdrawn from the patient, or I.V. port, to the time the contaminated needle is safety discarded.
Polymedicure had a similar technology for needle protection and sells intravenous safety catheters which is different from B. Braun patent.
European patent office (EPO) has rejected three B. Braun patents. The patent battle lasted for eight years between B. Braun and Polymedicure.
Now Polymedicure can freely use the European market. According to Himanshu Baid, MD- Polymedicure, the patent war was fought in following countries Germany, Netherlands, Spain and Italy.